Isolated anti-HBc among HIV-infected patients in Istanbul, Turkey

HIV Clinical Trials

Volumn 14, Issue 1, 2013, Pages 17-20

  Karaosmanoglu, Hayat ^a   Aydin, Ozlem ^a   Nazlican, Ozcan ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

HIV; isolated anti HBc; prevalence

Indexed keywords

HEPATITIS B CORE ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; AGED; ANTIGEN PURIFICATION; ARTICLE; BLOOD DONOR; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG USE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TURKEY (REPUBLIC);

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ENDEMIC DISEASES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TURKEY; VIRAL LOAD; YOUNG ADULT;

EID: 84873393926     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1310/hct1401-17     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Rec Rep. 2001;50:1-42
2. Jindal N, Arora U, Singh K. Prevalence of human ?mmunodeficiency virus, HBV, HCV in three groups of populations at high risk of HIV Infection in Amristar, Northern India. Jpn J Infect Dis. 2008;61:79-81 (Pubitemid 351338538)
3. Weber R, Sabin CA, Friis-Møller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166(15):1632-1641 (Pubitemid 44232373)
4. Rockstroh JK. Management of hepatitis B and C in HIV coinfected patients. J Acquir Immune Defic Syndr. 2003;34:59-65
5. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S. Serological pattern "anti HBc alone'': report on a workshop. J Med Virol. 62:450-455
6. Berger A, Doerr HW, Rabenau HF, Weber B. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology. 2000;44:71-76
7. Bukhtiari N, Hussain T, Iqbal M, Malik AM, Qureshi AH, Hussian A. Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc. 2003;53:136-140
8. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini- Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically signifi cant or purely "occult"? Hepatology. 2001;34:194-203 (Pubitemid 32591500)
9. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B infection. J Hepatol. 2007;46:160-170
10. Toy M, Onder FO, Wormann T, Bozdayi AM, Schalm SW. Age- and region-specifi c hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis. 2011;11:337
11. Santos EA, Yoshida CF, Rolla VC, et al. Frequent occult hepatitis B virus infection in patients infected with human immunodefi ciency virus type 1. Eur J Clin Microbiol Infect Dis. 2003;22:92-98 (Pubitemid 36349970)
12. Piroth L, Binquet C, Vergne M, et al. The evolution of hepatitis of hepatitis B virus serological patterrns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol. 2002;36:681-686 (Pubitemid 34499406)
13. Osborn MK, Guest JL, Rimland D. Hepatitis B and HIV coinfection: relation of different serological patterns to survival and liver disease. HIV Med. 2007;8:271-279 (Pubitemid 46901525)
14. French AL, Operskkalski E, Peters M, et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis. 2007;195:1437-1442 (Pubitemid 46717461)
15. Perez-Rodriguez MT, Sopena B, Crespo M, et al. Clinical significance of ''anti-HBc alone'' in human immunodeficiency virus-positive patients. World J Gastroenterol. 2009;15:1237-1242
16. Firnhaber C, Viana R, Reyneke A, et al. Occult hepatitis B virus infections in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesbug, South Africa. Int J Infect Dis. 2009;13:488-492
17. Remazani A, Banifazi M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010;4:658-661
18. Colomina-Rodriguez J, González-Garcia D, Burgos-Teruel A, Fernández-Lorenz N, Guerrero-Espejo A. Signifi cance of hepatitis core antibody as the only marker of hepatitis. Enferm Infecc Microbiol Clin. 2005;23:80-85 (Pubitemid 40486605)
19. Altunay H, Kosan E, Birinci, Aksoy A, Kirali K. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplifi cation test (NAT) based on transcription- mediated amplification (TMA) and HBV discrimination. Transfus Apher Sci. 2010;43:265-268
20. Kaya S, Kesbic H, Alanoglu G, Aridogan BC, Cetin ES, Tas T, Demirci M. The investigation of isolated hepatitis B virus core antibodies in blood donors. Nobel Medicus. 2009;5:17-21
21. Yildirim B, Barut S, Bulut Y, Yenisehirli G, Ozdemir M. Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: a populationbased study. Turk J Gastroenterol. 2009;20:27-30
22. Shire NJ, Rouster SD, Rajicic N, Sherman KE. Occult hepatitis B in HIV-infected patients. J Acquire Immune Defi c Syndr. 2004;36:869-875 (Pubitemid 38859354)
23. Hofer M, Joller-Jemelka HI, Grob PJ, Lüthy R, Opravil M. Frequent chonic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis. 1998;17:6-13 (Pubitemid 28072282)
24. Gandhi RT, Wurcel A, Lee H, et al. Isolated antibody to hepatitis B core antigen in human immunodefi ciency vius type-1 infected individuals. Clin Infect Dis. 2003;36:1602-1605 (Pubitemid 36783346)
25. Gupta S, Singh S. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in North India. BMC Infect Dis. 2010;10:53
26. Neau D, Winnock M, Galperine T, et al. Isolated antibodiest against the core antigen of hepatitis B in HIV-infected patinets. HIV Med. 2004;5:171-173 (Pubitemid 38765284)
27. Liang SH, Chen TJ, Lee SS, et al. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acquire Immune Defi c Syndr. 2010:54;122-128.